Young Investigator Award Prize Oral

K MANERA1,2, A TONG1,2, J CRAIG1,2, J SHEN3, S JESUDASON4,5, Y CHO6,7,8, B SAUTENET1,2,9,M HOWELL1,2, A WANG10, E BROWN11, G BRUNIER12, J PERL13, J DONG14, M WILKIE15, R MEHROTRA16, R PECOITS-FILHO17, S NAICKER18, T DUNNING19, D JOHNSON6,7,8,20,21 1Sydney School of...
  • 14 June 2018
Read More
A VAN ZWIETEN1,2, G WONG1,2,3, M RUOSPO4,5, S PALMER6, A TEIXEIRA-PINTO1,2, M BARULLI7, A IURILLO7, V SAGLIMBENE1,4, P NATALE4,8, L GARGANO4, M MURGO4, C LOY1,9, R TORTELLI7, J CRAIG1,2,10, D JOHNSON11,12, M TONELLI13, J  HEGBRANT4, C WOLLHEIM4, G LOGROSCINO7,14, G...
  • 14 June 2018
Read More
B SMYTH1,2, K HOWARD1, L ZUO3, J DE ZOYSA4,5, C CHAN6, N GRAY7,8, A CASS9, M GALLAGHER2,10,11, V PERKOVIC2, M JARDINE2,11 1Sydney School of Public Health, University of Sydney, Sydney, Australia, 2The George Institute for Global Health, UNSW, Sydney, Australia,...
  • 14 June 2018
Read More
T YING1,2,A TRAN2, AC WEBSTER2, H PILMORE3, P KELLY2, JS GILL4, S KLARENBACH5, S CHADBAN1,2, RL MORTON2 1Royal Prince Alfred Hospital, Camperdown, Australia, 2University of Sydney, Camperdown, Australia, 3Auckland City Hospital, Auckland, New Zealand, 4University of British Columbia, Vancouver, Canada,...
  • 14 June 2018
Read More
V SHEN1, G ZHANG1, M HU2, J ZHOU1, S ROBINSON1, H MCCARTHY1, Y WANG2, Q CAO2, G ZHENG2, N ROGERS2, T BARBOUR3, I ALEXANDER4, D HARRIS2, S ALEXANDER1, Y WANG1 1Centre for Kidney Research, The Children’s Hospital at Westmead, Sydney,...
  • 14 June 2018
Read More
M LEE1,2, P MOUNT1, M KATERELOS1, K GLEICH1, D POWER1,2 1Austin Health, Heidelberg, Australia, 2Department of Medicine, The University of Melbourne, Heidelberg, Australia Aim: To determine the roles of fatty acid oxidation (FAO) and glycolysis in renal fibrosis. Background: Changes...
  • 14 June 2018
Read More
C HUANG1, H YI1, Y SHI1, Q CAO1, X-M CHEN1, C POLLOCK1 1University of Sydney, St Leonards, Australia Aim: To identify the role of KCa3.1 in mitochondrial quality control in diabetic nephropathy. Background: Mitochondrial dysfunction is involved in the pathogenesis...
  • 14 June 2018
Read More
Y SHI1, Y ZHAO2, CL HUANG1, X CHEN1, C POLLOCK1 1Kolling Institute, University of Sydney, Royal North Shore Hospital, Sydney, New South Wales; 2The Second Hospital, Dalian Medical University, China Aim: To define the role of RIPK3 blocking in alleviating renal fibrogenesis....
  • 3 August 2017
Read More
CS HANSON1,2, G RAMAN2, Y ZHANG2, AF RALPH1,2, AJU1,2, LJ JAMES1,2,  AK VIECELLI3, S MCTAGGART4, A WALKER5, J DIONNE6, T BLYDTHANSEN6, H CURRIER7, M MICHAEL7, S WENDERFER7, M ZAPPITELLI9, A DART10, S FURTH11, AA EDDY6, S SAMUEL, J GROOTHOFF12, NJA...
  • 3 August 2017
Read More
H HUTTON1,2, J OOI1, S HOLDSWORTH1,2,  AR KITCHING1,2 1Centre for Inflammatory Diseases, Monash University, Clayton, Victoria; 2Department of Nephrology, Monash Health, Clayton, Victoria Aim: To determine the therapeutic potential of inflammasome inhibition in ANCA-associated vasculitis (AAV). Background: The NLRP3 inflammasome innate...
  • 3 August 2017
Read More
Categories